Ophthalmology

Uzm. Dr. Tuğba Aydoğan Gezginaslan

Doctor and researcher Ümraniye Eğitim ve Araştırma Hastanesi İstanbul
Macular EdemaDiabetic RetinopathyRetinal DiseasesDiabetes Mellitus
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Macular Edema 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Diabetic Retinopathy 7 publications
  • Retinal Diseases 2 publications
  • Diabetes Mellitus 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyOphthalmologysaglik.gov.trFrom source
  • InstitutionÜmraniye Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workMacular EdemaExtracted from 8 publications · Model version —From source
  • Publications24 publicationsOpenAlex, Europe PMC, ORCIDFrom source
  • ORCID0000-0002-2624-7496ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://umraniyeah.saglik.gov.tr/TR-1512769/doktorlarimiz.html#tugba-aydogan-gezginaslansaglik.gov.tr

Scientific work

Publications on Macular Edema

24 publications

  1. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261480211 PMID 42630057 Open-access full textSource: OpenAlex

  2. Assessment of Dietary Nutritional Profile in Turkish Patients with Age-Related Macular Degeneration

    Turkish Journal of Ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.26641 PMID 42343583 Open-access full textSource: OpenAlex

  3. Comparison of Optical Coherence Tomography Biomarkers in Nonproliferative and Proliferative Diabetic Retinopathy: Marmasia Study Group Report No. 2

    Turkish journal of ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.24196 PMID 42928578 Open-access full textSource: Europe PMC

  4. Sequential Cilioretinal Artery Occlusion and Acute Anterior Uveitis as the Initial Ocular and Systemic Manifestation of Systemic Lupus Erythematosus: A Case Report

    Ocular Immunology and Inflammation, 2026

    DOI 10.1080/09273948.2026.2696519 PMID 42461774 Source: ORCID

  5. Evaluation of aflibercept treatment outcomes using optical coherence tomography angiography in macular telangiectasia type 1

    BMC Ophthalmology, 2026

    DOI 10.1186/s12886-026-04634-x PMID 41578203 Open-access full textSource: ORCID

  6. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

    Eye, 2025

    DOI 10.1038/s41433-025-03928-6 PMID 40664760 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  7. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group

    European Journal of Ophthalmology, 2024

    DOI 10.1177/11206721241280737 PMID 39234628 Source: OpenAlex

  8. One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13

    Seminars in Ophthalmology, 2024

    DOI 10.1080/08820538.2024.2324450 PMID 39087722 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  9. Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10

    International Ophthalmology, 2024

    DOI 10.1007/s10792-024-03251-1 PMID 39317810 Source: OpenAlex

  10. Evaluation of optical coherence tomography and optical coherence tomography angiography findings of fibromyalgia

    International Ophthalmology, 2024

    DOI 10.1007/s10792-024-03363-8 PMID 39681820 Open-access full textSource: ORCID

View all 24 publications